Global Health Limited (MEDANTA) — Cash Flow Reinvestment Rate
Global Health Limited (MEDANTA) has a Cash Flow Reinvestment Rate of 1.26x as of September 2025, reinvesting Rs4.13 Billion (capex Rs4.13 Billion ) from operating cash flow of Rs3.29 Billion. See MEDANTA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Global Health Limited Cash Flow Reinvestment Rate (2019–2026)
Historical reinvestment intensity for Global Health Limited across 8 annual periods. For the full cash flow conversion analysis, see Global Health Limited (MEDANTA) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Global Health Limited (2019–2026)
Year-by-year capital reinvestment analysis for Global Health Limited. See financial agility of Global Health Limited to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 1.55x | Rs11.68 Billion | Rs7.53 Billion | Rs9.79 Billion | ▼ -21.9% |
| 2025 | 1.98x | Rs12.37 Billion | Rs6.24 Billion | Rs5.17 Billion | ▲ +68.8% |
| 2024 | 1.18x | Rs7.19 Billion | Rs6.12 Billion | Rs2.79 Billion | ▲ +31.0% |
| 2023 | 0.90x | Rs5.78 Billion | Rs6.45 Billion | Rs2.36 Billion | ▼ -59.8% |
| 2022 | 2.23x | Rs6.95 Billion | Rs3.11 Billion | Rs2.74 Billion | ▲ +40.3% |
| 2021 | 1.59x | Rs3.85 Billion | Rs2.42 Billion | Rs1.46 Billion | ▲ +1.2% |
| 2020 | 1.57x | Rs2.75 Billion | Rs1.75 Billion | Rs1.88 Billion | ▼ -19.0% |
| 2019 | 1.94x | Rs3.00 Billion | Rs1.54 Billion | Rs3.00 Billion | — |